Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri
Author:
Affiliation:
1. Division of Rheumatology; Department of Internal Medicine; Korea University College of Medicine; Seoul South Korea
2. Department of Rheumatology; Hanyang University Hospital for Rheumatic Diseases; Seoul South Korea
Funder
Korea Healthcare Technology R&D Project
Ministry for Health and Welfare
Republic of Korea
Publisher
Wiley
Subject
Rheumatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12822/fullpdf
Reference24 articles.
1. Rheumatoid arthritis. Pathophysiology and implications for therapy;Harris;N Engl J Med,1990
2. Genome scan meta-analysis of rheumatoid arthritis;Choi;Rheumatology (Oxford),2006
3. TNF alpha-a pivotal role in rheumatoid arthritis?;Brennan;Br J Rheumatol,1992
4. Infliximab and methotrexate in the treatment of rheumatoid Arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group;Lipsky;N Engl J Med,2000
5. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition;Genovese;N Engl J Med,2005
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis;Seminars in Arthritis and Rheumatism;2024-02
2. Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study;Rheumatology and Therapy;2023-10-31
3. Switching biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in patients with rheumatoid arthritis;Modern Rheumatology Journal;2023-07-13
4. Factors associated with selection of targeted therapy in patients with rheumatoid arthritis;PLOS ONE;2023-01-10
5. ACCP-negative rheumatoid arthritis – clinical and immunological features;Rheumatology Science and Practice;2022-07-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3